Form 4: Tesla Director Kathleen Wilson-Thompson Executes Stock Sales Under 10b5-1 Plan
SEC Form 4 Filing
Tesla director Kathleen Wilson-Thompson sold a total of 100,000 shares of common stock on January 6, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Kathleen Wilson-Thompson, a director at Tesla, sold 100,000 shares of Tesla common stock on January 6, 2025.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 12, 2024.
- The sales occurred in multiple transactions at varying prices, ranging from $402.230 to $426.300 per share.
- Additionally, 100,000 non-qualified stock options were exercised at a price of $14.99 per share.
- After these transactions, Ms. Wilson-Thompson directly owns 5,400 shares of Tesla common stock and 120,948 derivative securities.
Sentiment
Score: 5
Explanation: The document reflects routine insider trading activity under a pre-arranged plan, which is neither positive nor negative in itself. The sentiment is neutral.
Risks
- Large sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.
- The use of a 10b5-1 plan indicates pre-planned sales, but the timing and volume could still raise questions among investors.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of trading on non-public information.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among executives and directors at publicly traded companies, including Tesla's peers such as General Motors (GM) and Ford (F).
- Similar filings are regularly made by insiders at these companies, reflecting routine stock transactions.
- The volume of shares sold by Ms. Wilson-Thompson is not unusual for a director, and the price range is consistent with market fluctuations for Tesla stock.
Stakeholder Impact
- The stock sales could have a minor impact on the share price, but the pre-planned nature of the transactions should mitigate any significant negative reaction.
- The transactions do not directly impact employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date the 10b5-1 trading plan was adopted by the reporting person. |
| 01/06/2025 | Date of the stock sales and option exercise. |
| 01/08/2025 | Date the Form 4 was signed. |
| 06/18/2026 | Expiration date of the non-qualified stock options. |
Keywords
Tesla, insider trading, stock sale, Form 4, Kathleen Wilson-Thompson, 10b5-1 plan, stock options, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.